-
-
-
-
-
-
-
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026
-
-
-
-
-
-
-
Protagonist Therapeutics Reports Granting of Inducement Awards
-
-
-
-
-
-
-
Protagonist Therapeutics (PTGX) PT Raised to $119 at Barclays following Icotyde approval
-
-
-
-
-
-
-
Protagonist Therapeutics (PTGX) PT Raised to $112 at Citizens: 2 Approvals This Year
-
-
-
-
-
-
-
Protagonist's (PTGX) Economics Can Change After Takeda Opt-out - Citizens
-
-
-
-
-
-
-
Protagonist Therapeutics (PTGX) Said to Be Mentioned Cautiously Regarding M&A
-
-
-
-
-
-
-
Jefferies says this stock offers favorable setup with further upside potential
-
433,981 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

